FDA approves first product for Coralville-based IDx
BPC Staff Apr 12, 2018 | 8:53 pm
<1 min read time70 wordsAll Latest News, Health & Wellness, Tech & Innovation
Corridor Business Journal: IDx, a University of Iowa spinout company based in Coralville, has received FDA approval to market IDx-DR, the first medical device to use artificial intelligence to detect greater than a mild level of the eye disease diabetic retinopathy in adults who have diabetes. IDx recently announced a move to larger quarters in the Oakdale Research Park in Coralville and plans to expand staff as it commercializes IDx-DR.
Facebook Notice for EU! You need to login to view and post FB Comments!